Most Cited Articles of Neuropharmacology in 2008

Oxidative stress in psychiatric disorders: evidence base and therapeutic implicationsInternational Journal of Neuropsychopharmacology2008669
A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depressionInternational Journal of Neuropsychopharmacology2008644
Mechanisms of ischemic brain damageNeuropharmacology2008617
Neuroprotection for ischemic stroke: past, present and futureNeuropharmacology2008580
Regulation of NMDA receptor subunit expression and its implications for LTD, LTP, and metaplasticityNeuropharmacology2008481
A randomized, double-blind clinical trial on the efficacy of cortical direct current stimulation for the treatment of major depressionInternational Journal of Neuropsychopharmacology2008367
Several major antiepileptic drugs are substrates for human P-glycoproteinNeuropharmacology2008239
Multiple pathways involved in the biosynthesis of anandamideNeuropharmacology2008224
Lipid rafts, cholesterol, and the brainNeuropharmacology2008215
Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptorsNeuropharmacology2008213
Histone deacetylase inhibitors up-regulate astrocyte GDNF and BDNF gene transcription and protect dopaminergic neuronsInternational Journal of Neuropsychopharmacology2008208
Functional interactions between dopamine, serotonin and norepinephrine neurons: an in-vivo electrophysiological study in rats with monoaminergic lesionsInternational Journal of Neuropsychopharmacology2008198
Effects of acute and repeated restraint stress on endocannabinoid content in the amygdala, ventral striatum, and medial prefrontal cortex in miceNeuropharmacology2008180
How the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systemsNeuropharmacology2008170
Serotonin and GI clinical disordersNeuropharmacology2008166
The cost of cerebral ischaemiaNeuropharmacology2008165
Serotonin and emotional processing: does it help explain antidepressant drug action?Neuropharmacology2008162
Bioenergetics of cerebral ischemia: a cellular perspectiveNeuropharmacology2008151
Interactions between histamine H3 and dopamine D2 receptors and the implications for striatal functionNeuropharmacology2008142
The novel selective PDE9 inhibitor BAY 73-6691 improves learning and memory in rodentsNeuropharmacology2008142
Identification of the sites of 2-arachidonoylglycerol synthesis and action imply retrograde endocannabinoid signaling at both GABAergic and glutamatergic synapses in the ventral tegmental areaNeuropharmacology2008140
Intracerebroventricular injection of propionic acid, an enteric bacterial metabolic end-product, impairs social behavior in the rat: implications for an animal model of autismNeuropharmacology2008140
Antagonistic cannabinoid CB1/dopamine D2 receptor interactions in striatal CB1/D2 heteromers. A combined neurochemical and behavioral analysisNeuropharmacology2008139
Inhibition of glial inflammatory activation and neurotoxicity by tricyclic antidepressantsNeuropharmacology2008138
Transcriptional regulation at a HTR1A polymorphism associated with mental illnessNeuropharmacology2008137